|
1
|
Hanewinckel R, van Oijen M, Ikram MA and
van Doorn PA: The epidemiology and risk factors of chronic
polyneuropathy. Eur J Epidemiol. 31:5–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Callaghan BC, Price RS, Chen KS and
Feldman EL: The importance of rare subtypes in diagnosis and
treatment of peripheral neuropathy: A review. JAMA Neurol.
72:1510–1518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lehmann HC, Wunderlich G, Fink GR and
Sommer C: Diagnosis of peripheral neuropathy. Neurol Res Pract.
2:202020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McDonald CM: Clinical approach to the
diagnostic evaluation of hereditary and acquired neuromuscular
diseases. Phys Med Rehabil Clin N Am. 23:495–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cuthbert SC and Goodheart GJ Jr: On the
reliability and validity of manual muscle testing: A literature
review. Chiropr Osteopat. 15:42017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lanska DJ and Goetz CG: Romberg's sign:
Development, adoption, and adaptation in the 19th century.
Neurology. 55:1201–1206. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suvarna KS, Layton C and Bancroft JD:
Bancroft's Theory and Practice of Histological Techniques. 7th
Edition. Churchill Livingstone; 2012
|
|
8
|
Rubens O, Logina I, Kravale I, Eglîte M
and Donaghy M: Peripheral neuropathy in chronic occupational
inorganic lead exposure: A clinical and electrophysiological study.
J Neurol Neurosurg Psychiatry. 71:200–204. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weimer LH: Medication-induced peripheral
neuropathy. Curr Neurol Neurosci Rep. 3:86–92. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ammendola A, Tata MR, Aurilio C, Ciccone
G, Gemini D, Ammendola E, Ugolini G and Argenzio F: Peripheral
neuropathy in chronic alcoholism: A retrospective cross-sectional
study in 76 subjects. Alcohol Alcohol. 36:271–275. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
López-Hernández N, García-Escrivá A,
Pampliega-Pérez A, Alvarez-Saúco M, Martín-Estefanía C and
Asensio-Asensio M: Peripheral and optical myeloneuropathy in a
folic acid deficient alcoholic patient. Rev Neurol. 37:726–729.
2003.(In Spanish). PubMed/NCBI
|
|
12
|
Dyck PJ, Oviatt KF and Lambert EH:
Intensive evaluation of referred unclassified neuropathies yields
improved diagnosis. Ann Neurol. 10:222–226. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hemmer B, Glocker FX, Schumacher M,
Deuschl G and Lücking CH: Subacute combined degeneration: Clinical,
electrophysiological, and magnetic resonance imaging findings. J
Neurol Neurosurg Psychiatry. 65:822–827. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stino AM, Naddaf E, Dyck PJ and Dyck PJB:
Chronic inflammatory demyelinating polyradiculoneuropathy
diagnostic pitfalls and treatment approach. Muscle Nerve.
63:157–169. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Illes Z and Blaabjerg M: Cerebrospinal
fluid findings in Guillain-Barré syndrome and chronic inflammatory
demyelinating polyneuropathies. Handb Clin Neurol. 146:125–138.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dalakas MC, Latov N and Kuitwaard K:
Intravenous immunoglobulin in chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP): Mechanisms of action and clinical
and genetic considerations. Expert Rev Neurother. 22:953–962. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brown R and Ginsberg L: POEMS syndrome:
Clinical update. J Neurol. 266:268–277. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dispenzieri A: POEMS syndrome. Blood Rev.
21:285–299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chaudhry HM, Mauermann ML and Rajkumar SV:
Monoclonal gammopathy-associated peripheral neuropathy: Diagnosis
and management. Mayo Clin Proc. 92:838–850. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moshe-Lilie O, Ensrud E, Ragole T, Nizar
C, Dimitrova D and Karam C: CIDP mimics: A case series. BMC Neurol.
21:942021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mauermann ML, Sorenson EJ, Dispenzieri A,
Mandrekar J, Suarez GA and Dyck PJ and Dyck PJ: Uniform
demyelination and more severe axonal loss distinguish POEMS
syndrome from CIDP. J Neurol Neurosurg Psychiatry. 83:480–486.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, Liu P, Ji LL, Wu S, Feng GD, Wang
X and Dong JH: Clinical and electrophysiological profiles in early
recognition of polyneuropathy, organomegaly, endocrinopathy,
M-protein, and skin changes syndrome. Chin Med J (Engl).
132:1666–1672. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kyle RA and Rajkumar SV: Monoclonal
gammopathy of undetermined significance. Neoplastic Diseases of the
Blood. Wiernik P, Goldman J, Dutcher J and Kyle R: 5th Edition.
Springer; New York, NY: 2013, View Article : Google Scholar
|
|
24
|
Pan Q, Li J, Li F, Zhou D and Zhu Z:
Characterizing POEMS syndrome with 18F-FDG PET/CT. J Nucl Med.
56:1334–1337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi XF, Hu SD, Wu LL, Chen XY, Wu JN, Yu
XQ, Li DY, Chen M, Liu YC, Zhu Y and Xi XD: Lymphadenopathy in
POEMS syndrome: A correlation between clinical features and imaging
findings. Int J Clin Exp Pathol. 13:21–25. 2020.PubMed/NCBI
|
